Epiliquid Holding, Inc

This study is testing a new blood test designed to detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 200 people—some with confirmed liver cancer and some with liver cirrhosis but no cancer. The goal is to see if the test can ac…

This study is testing a new blood test designed to detect colorectal cancer early. Researchers will enroll 3,200 average-risk adults aged 45-75 who are scheduled for a routine colonoscopy. They will compare the results of the blood test to the colonoscopy findings to see how accu…